E799 E799 (Rifampin 300 mg)
Pill imprint E799 E799 has been identified as Rifampin 300 mg.
Rifampin is used in the treatment of bartonellosis; mycobacterium avium-intracellulare, treatment; leprosy; haemophilus influenzae prophylaxis; endocarditis (and more), and belongs to the drug class rifamycin derivatives. Risk cannot be ruled out during pregnancy. Rifampin 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- E799 E799
- 300 mg
- 18.00 mm
- Prescription only
- Drug Class:
- Rifamycin derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Sandoz Pharmaceuticals Inc
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
D&C Yellow No. 10
|NDC Code||Manufacturer / Repackager|
|51079-0890||UDL Laboratories Inc|
|63739-0415||McKesson Packaging Services|
|54868-4683||Physicians Total Care Inc (repackager)|
|54569-5770||A-S Medication Solutions, LLC (repackager)|
|16590-0714||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about rifampin
- Rifampin capsules
- Rifampin Intravenous (Advanced Reading)
- Rifampin Oral, Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.